Antisense Therapeutics (ASX:ANP) Share Price and News

Market Cap (7-Mar) TBC	Close (30-Jun) $0.059 0 (0%)	Volume (30-Jun) 4,352,698	Shortsold (24-Jul) 256 (0.00%) (719th)
52w High $0.000	52w Low $0.000	P/E -	EPS -

	Subject
	ANP ANP Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK
	1 (current) 2 3
	ANP ANP Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial
	ANP ANP Ann: Shareholder Newsletter
	ANP ANP Ann: Final Director's Interest Notice
	ANP ANP Ann: Change of Director's Interest Notice (JG)
	ANP ANP Ann: Initial Director's Interest Notice
	ANP ANP Ann: Chief Executive Officer and Managing Director Appointment
	ANP ANP Ann: PIIb DMD trial approved in Bulgaria- UK, Australia advancing
	ANP ANP Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	ANP ANP Ann: Dosing commenced in the ATL1102 toxicology study
	ANP ANP Ann: Notice under Section 708A
	ANP ANP Ann: Application for quotation of securities - ANP
	ANP ANP Ann: Proposed issue of securities - ANP
	ANP ANP Ann: Receipt of R&D Tax Incentive Payment
	ANP ANP Ann: Half Yearly Report and Accounts
	ANP ANP Ann: Presentation at International Conference on DMD
	ANP ANP Ann: First approval for ATL1102 Phase IIb DMD clinical trial
	ANP ANP Ann: Limb Girdle Muscular Dystrophy R2 animal study commenced
	ANP ANP Ann: Positive outcomes in DMD combination therapy animal study
	ANP ANP Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	ANP ANP Ann: Notification regarding unquoted securities - ANP
	ANP ANP Ann: Phase IIb DMD CTA submitted for trial conduct in Europe
	ANP ANP Ann: Application for quotation of securities - ANP
	ANP ANP Ann: Final Director's Interest Notice (GWP)
	ANP ANP Ann: Results of Annual General Meeting
	ANP ANP Ann: AGM Presentation
	ANP ANP Ann: Antisense Therapeutics CEO announces retirement
	ANP ANP Ann: ATL1102 tox study to support clinical program in the US
	ANP ANP Ann: Change of Registry Address
	ANP ANP Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	ANP ANP Ann: Appendix 4G
	ANP ANP Ann: Corporate Governance Statement
	ANP ANP Ann: Annual Report
	ANP ANP Ann: Notice of Annual General Meeting
	ANP ANP Ann: Non-Executive Director Retirement
	ANP ANP Ann: Receipt of further R&D Tax Incentive Payment
	ANP ANP Ann: Change of Director's Interest Notice (GP)
	ANP ANP Ann: Company Appointment Chief Commercial Officer
	ANP ANP Ann: Change of Director's Interest Notice (GP)
	ANP ANP Ann: Change of Director's Interest Notice (GP)
	ANP ANP Ann: Dosing commenced in DMD combination therapy study
	ANP ANP Ann: ATL1102 Revised Clinical Development Plans Presentation
	ANP ANP Ann: ATL1102 Revised Plans accelerate reporting of unblinded data
	ANP ANP Ann: Appendix 4E and Full Year Statutory Accounts
	ANP ANP Ann: Ceasing to be a substantial holder
	ANP ANP Ann: Reinstatement to Official Quotation
	ANP ANP Ann: Response to ASX Query
	ANP ANP Ann: Long Covid-19 Collaboration Outcomes Presentation
	ANP ANP Ann: Long COVID study identifies diagnostic & therapeutic targets
	ANP ANP Ann: Voluntary Suspension

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
06-Mar	$0.08	699,685	+0.00 (1.20%)
05-Mar	$0.08	284,901	0.00 (2.35%)
04-Mar	$0.09	569,939	0.00 (3.41%)
01-Mar	$0.09	2,253,232	+0.00 (1.15%)
29-Feb	$0.09	1,694,862	+0.01 (7.41%)
28-Feb	$0.08	5,442,601	+0.01 (10.96%)
27-Feb	$0.07	543,657	+0.00 (4.29%)
26-Feb	$0.07	410,931	0.00 (1.41%)
23-Feb	$0.07	124,523	+0.00 (2.90%)
22-Feb	$0.07	291,500	0.00 (1.43%)
21-Feb	$0.07	679,656	+0.00 (1.45%)
20-Feb	$0.07	140,000	0.00 (1.43%)
19-Feb	$0.07	332,887	0.00 (2.78%)
16-Feb	$0.07	383,238	+0.00 (1.41%)
15-Feb	$0.07	442,144	+0.00 (1.43%)
9 up, 6 down, and 0 flat days

High $0.06	Low $0.06	Trades 100	Turnover $254,071	Volume 4,352,698
30 June 2023 at 4:10pm

High $0.06	Low $0.06	Trades 100	Turnover $254,071	Volume 4,352,698
30 June 2023 at 4:10pm

Antisense Therapeutics Health Care

$0.059 -0.003 (-4.84%)

$0.059 -0.003 (-4.84%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices